Studies Coordinating Centre, Laboratory of Hypertension, University of Leuven, Campus Sint Rafaël, Kapucijnenvoer 35, Block D, Level 00, Box 7001, B-3000 Leuven, Belgium.
Hypertension. 2011 Mar;57(3):397-405. doi: 10.1161/HYPERTENSIONAHA.110.156828. Epub 2011 Jan 24.
To analyze sex-specific relative and absolute risks associated with blood pressure (BP), we performed conventional and 24-hour ambulatory BP measurements in 9357 subjects (mean age, 52.8 years; 47% women) recruited from 11 populations. We computed standardized multivariable-adjusted hazard ratios for associations between outcome and systolic BP. During a course of 11.2 years (median), 1245 participants died, 472 of cardiovascular causes. The number of fatal combined with nonfatal events was 1080, 525, and 458 for cardiovascular and cardiac events and for stroke, respectively. In women and men alike, systolic BP predicted outcome, irrespective of the type of BP measurement. Women compared with men were at lower risk (hazard ratios for death and all cardiovascular events=0.66 and 0.62, respectively; P<0.001). However, the relation of all cardiovascular events with 24-hour BP (P=0.020) and the relations of total mortality (P=0.023) and all cardiovascular (P=0.0013), cerebrovascular (P=0.045), and cardiac (P=0.034) events with nighttime BP were steeper in women than in men. Consequently, per a 1-SD decrease, the proportion of potentially preventable events was higher in women than in men for all cardiovascular events (35.9% vs 24.2%) in relation to 24-hour systolic BP (1-SD, 13.4 mm Hg) and for all-cause mortality (23.1% vs 12.3%) and cardiovascular (35.1% vs 19.4%), cerebrovascular (38.3% vs 25.9%), and cardiac (31.0% vs 16.0%) events in relation to systolic nighttime BP (1-SD, 14.1 mm Hg). In conclusion, although absolute risks associated with systolic BP were lower in women than men, our results reveal a vast and largely unused potential for cardiovascular prevention by BP-lowering treatment in women.
为了分析与血压(BP)相关的性别特异性相对和绝对风险,我们在 11 个人群中招募了 9357 名受试者(平均年龄 52.8 岁;47%为女性),进行了常规和 24 小时动态血压测量。我们计算了结局与收缩压之间关联的标准化多变量调整后的危险比。在 11.2 年的研究过程中(中位数),1245 名参与者死亡,其中 472 人死于心血管疾病。致命性和非致命性事件的数量分别为心血管和心脏事件以及中风的 1080、525 和 458。无论采用何种血压测量方式,收缩压都可以预测女性和男性的结局。与男性相比,女性的风险较低(死亡和所有心血管事件的危险比分别为 0.66 和 0.62;P<0.001)。然而,24 小时血压与所有心血管事件的关系(P=0.020)以及总死亡率(P=0.023)和所有心血管事件(P=0.0013)、脑血管事件(P=0.045)和心脏事件(P=0.034)与夜间血压的关系在女性中比在男性中更为陡峭。因此,与 24 小时收缩压(1-SD,13.4mmHg)相关的所有心血管事件中,女性潜在可预防事件的比例高于男性(35.9% vs 24.2%),与全因死亡率(23.1% vs 12.3%)和心血管(35.1% vs 19.4%)、脑血管(38.3% vs 25.9%)和心脏(31.0% vs 16.0%)事件与夜间收缩压(1-SD,14.1mmHg)相关的潜在可预防事件的比例高于男性。总之,尽管女性与收缩压相关的绝对风险低于男性,但我们的研究结果表明,通过降压治疗对女性进行心血管预防具有巨大且尚未充分利用的潜力。